Energy.
Microvascular hemolysis, also known as microangiopathic hemolytic anemia, can generally be seen in acute renal failure, thrombotic thrombocytopenic purpura, disseminated cancer, and many other diseases, it is due to these diseases on the microvessels to cause some damage, resulting in mechanical damage to red blood cells.
The treatment of microangiopathic hemolytic anemia is mainly related to its etiology, and each person needs to be treated for his or her own causes of microvascular damage. For acute renal failure can choose to take furosemide and other diuretics to accelerate the discharge of toxic metabolites; thrombotic thrombocytopenic purpura, disseminated cancer can choose to methylprednisolone and other glucocorticosteroids and radiation therapy or chemotherapy.
If the diagnosis of microangiopathic hemolytic anemia is confirmed, it is recommended to go to the hospital to clarify the cause of the disease, and follow the advice and guidance of professional doctors to avoid delays.